Association of Supernumerary Sex Chromosome Aneuploidies With Venous Thromboembolism
JAMA · 2023
DOI: 10.1001/jama.2022.23897 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Alexander S F Berry und 7 weiteren Autor:innen. Beteiligte Einrichtung: Autism and Developmental Medicine Institute, Geisinger, Lewisburg, Pennsylvania. Hauptthemen laut MEDLINE: Aneuploidy, Venous Thromboembolism, Sex Chromosome Aberrations. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, NIMH NIH HHS.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Importance An increased risk of venous thromboembolism (VTE) has been reported in men with an additional sex chromosome. The association between other sex chromosome aneuploidies and VTE is not well characterized.
Objective
To determine if sex chromosome aneuploidy is associated with VTE. Design, Setting, and Participants Retrospective cohort study of sex chromosome aneuploidy and VTE, performed by analyzing X- and Y-chromosome dosage and VTE incidence in 642 544 individuals from 2 population-scale biobanks: the US Geisinger MyCode Community Health Initiative (N = 154 519) and the UK Biobank (N = 488 025); analysis was limited to participants self-identified as White because of inadequate sample sizes for other race and ethnicity groups. A total of 108 461 unrelated MyCode participants with electronic health record follow-up ranging from September 1996 to December 2020 and 418 725 unrelated British and Irish UK Biobank participants who attended the baseline assessment between March 2006 and October 2010, with follow-up extending to November 2020, were included in analyses of VTE. Exposures Sex chromosome aneuploidies. Main Outcomes and Measures Individuals with 1 primary inpatient VTE diagnosis, 2 primary outpatient VTE diagnoses, or a self-reported VTE diagnosis were defined as VTE cases. P values were adjusted for multiple comparisons.
Results
Identification of sex chromosome aneuploidy was undertaken among 642 544 individuals aged 18 to 90 years. Identification of a diagnosis of VTE was undertaken among 108 461 unrelated MyCode participants (65 565 [60.5%] female; mean age at last visit, 58.0 [SD, 17.6] years; median follow-up, 15.3 [IQR, 9.7] years) and among 418 725 unrelated UK Biobank participants (224 695 [53.7%] female; mean age at baseline interview, 56.9 [SD, 8.0] years; median follow-up, 12.0 [IQR, 1.6] years). Among MyCode participants, during 10 years of follow-up, 17 incident VTE events per 1353 person-years were detected among those with supernumerary sex chromosome aneuploidy (1.3% per person-year) compared with 2060 per 816 682 person-years among those with 46,XX or 46,XY (0.25% per person-year) (hazard ratio, 5.4 [95% CI, 3.4-8.7]; 10-year risk difference, 8.8% [95% CI, 4.2%-14.0%]; P < .001). Among UK Biobank participants, during 10 years of follow-up, 16 incident VTE events per 3803 person-years were detected among those with supernumerary sex chromosome aneuploidy (0.42% per person-year) compared with 4491 per 3 970 467 person-years among those with 46,XX or 46,XY (0.11% per person-year) (hazard ratio, 4.1 [95% CI, 2.5-6.7]; 10-year risk difference, 3.7% [95% CI, 1.4%-5.9%]; P < .001). Conclusions and Relevance Adults with supernumerary sex chromosome aneuploidies compared with 2 sex chromosomes had a small but statistically significant increased risk of VTE. Further research is needed to understand the clinical implications of this association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Autism and Developmental Medicine Institute, Geisinger, Lewisburg, Pennsylvania.
- Department of Population Health Sciences, Geisinger, Danville, Pennsylvania.
Förderung
- Medical Research Council
- NIMH NIH HHS
Zitieren
APA
Berry, A. S. F., Finucane, B. M., Myers, S. M., Abril, A., Kirchner, H. L., Ledbetter, D. H., Martin, C. L., & Oetjens, M. T. (2023). Association of Supernumerary Sex Chromosome Aneuploidies With Venous Thromboembolism. JAMA. https://doi.org/10.1001/jama.2022.23897
Vancouver
Berry ASF, Finucane BM, Myers SM, Abril A, Kirchner HL, Ledbetter DH, et al. Association of Supernumerary Sex Chromosome Aneuploidies With Venous Thromboembolism. JAMA. 2023. doi:10.1001/jama.2022.23897
BibTeX
@article{Berry2023,
author = {Berry, Alexander S F and Finucane, Brenda M and Myers, Scott M and Abril, Angela and Kirchner, H Lester and Ledbetter, David H and Martin, Christa Lese and Oetjens, Matthew T},
title = {Association of Supernumerary Sex Chromosome Aneuploidies With Venous Thromboembolism},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2022.23897}
}
EUVIMED